Miracle three-month course drug heralds the end of hepatitis C in Britain

Professor William Rosenberg (UCL Institute of Liver and Digestive Health) discusses new hepatitis C treatment, Sovaldi, saying: "We need a proper screening programme if we are to gain full benefit from these drugs". Read: Daily Mail